AbbVie and Capsida Biotherapeutics partner on eye disease gene therapies 27-Feb-2023 By Jane Byrne AbbVie and Capsida Biotherapeutics have expanded their strategic collaboration to develop genetic medicines for eye diseases with high unmet need.